Entity Common Stock, Shares Outstanding of Intellia Therapeutics, Inc. from 02 Jun 2016 to 13 Feb 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Intellia Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 02 Jun 2016 to 13 Feb 2026.
  • Intellia Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 13 Feb 2026 was 118,133,546, a 14% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Intellia Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 118,133,546 +14,616,086 +14% 13 Feb 2026 10-K 26 Feb 2026 2025 FY
Q3 2025 115,829,926 +13,981,354 +14% 31 Oct 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 107,346,886 +5,767,698 +5.7% 31 Jul 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 103,583,394 +7,107,973 +7.4% 30 Apr 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 103,517,460 14 Feb 2025 10-K 27 Feb 2025 2024 FY
Q3 2024 101,848,572 +12,293,681 +14% 01 Nov 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 101,579,188 +13,088,238 +15% 02 Aug 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 96,475,421 +8,334,443 +9.5% 03 May 2024 10-Q 09 May 2024 2024 Q1
Q3 2023 89,554,891 +10,870,852 +14% 03 Nov 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 88,490,950 +12,479,166 +16% 28 Jul 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 88,140,978 +12,287,108 +16% 28 Apr 2023 10-Q 04 May 2023 2023 Q1
Q3 2022 78,684,039 +4,264,625 +5.7% 31 Oct 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 76,011,784 +2,524,738 +3.4% 01 Aug 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 75,853,870 +7,700,273 +11% 28 Apr 2022 10-Q 05 May 2022 2022 Q1
Q3 2021 74,419,414 +15,338,631 +26% 29 Oct 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 73,487,046 +14,746,433 +25% 30 Jul 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 68,153,597 +16,773,118 +33% 30 Apr 2021 10-Q 06 May 2021 2021 Q1
Q3 2020 59,080,783 +10,198,515 +21% 30 Oct 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 58,740,613 +10,197,544 +21% 31 Jul 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 51,380,479 +5,669,554 +12% 01 May 2020 10-Q 07 May 2020 2020 Q1
Q3 2019 48,882,268 +5,462,965 +13% 25 Oct 2019 10-Q 31 Oct 2019 2019 Q3
Q2 2019 48,543,069 +5,342,436 +12% 26 Jul 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 45,710,925 +2,621,115 +6.1% 30 Apr 2019 10-Q 02 May 2019 2019 Q1
Q3 2018 43,419,303 +7,333,487 +20% 26 Oct 2018 10-Q 31 Oct 2018 2018 Q3
Q2 2018 43,200,633 +7,087,712 +20% 27 Jul 2018 10-Q 01 Aug 2018 2018 Q2
Q1 2018 43,089,810 +7,061,133 +20% 27 Apr 2018 10-Q 01 May 2018 2018 Q1
Q3 2017 36,085,816 +90,485 +0.25% 27 Oct 2017 10-Q 31 Oct 2017 2017 Q3
Q2 2017 36,112,921 +116,656 +0.32% 28 Jul 2017 10-Q 01 Aug 2017 2017 Q2
Q1 2017 36,028,677 26 Apr 2017 10-Q 02 May 2017 2017 Q1
Q3 2016 35,995,331 28 Oct 2016 10-Q 01 Nov 2016 2016 Q3
Q2 2016 35,996,265 02 Jun 2016 10-Q 03 Jun 2016 2016 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.